Tag: Cancer: Prostate
USPSTF Ruling Followed by Fall in Early Prostate Cancer Diagnoses
Rates per 100,000 men have dropped from 356.5 to 335.4 in men aged 50 to 74
Sociodemographic Factors Affect Prostate CA Treatment Initiation
Non-Hispanic black men more likely to begin active treatment, independent of clinical measures
Predictors ID’d for Switching to Active Tx in Prostate Cancer
Ethnicity influences patient decision to pursue active treatment and serial biopsies in active surveillance
QOL Not Affected by Active Surveillance of Prostate Cancer
Choosing no treatment and regular check-ups didn't seem to stress men with low-risk disease
Similar Outcomes for Robot-Assisted, Radical Prostatectomy
Similar functional outcomes at 12 weeks post-surgery for newly diagnosed localized prostate CA
Metastatic Prostate Cancer Cases Increasing in the United States
Findings highlight continued need for nationwide refinements in prostate cancer screening
MRI Feasible for Predicting Prostate CA in Unselected Sample
Adjusted odds ratio of prostate cancer significantly higher for MRI score than PSA
DNA-Repair Gene Mutations ID’d in Metastatic Prostate Cancer
Prevalence of 11.8 percent for germline DNA-repair gene mutations presumed to be deleterious
Docs Tending Away From Post-Prostatectomy Adjuvant RT
Urologists in Australia less favorable toward adjuvant radiotherapy in 2015 versus 2012
Benefits for Robotic-Assisted Laparoscopic Prostatectomy
Reduced risk of positive surgical margins versus open prostatectomy for patients with pT2 disease only
